Form 4 for TXG 10x Genomics, Inc.
Accepted 2023-07-21 00:00:00 ET · period of report 2023-07-19 · accession 0001610717-23-000215 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2023-07-21 | 2023-07-19 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $5.04 | +20.8K | 909.9K | +2% | +$105.1K |
| DT | 2023-07-21 | 2023-07-19 | TXG | Saxonov Serge | CEO, Dir | S - Sale+OE | $60.03 | -40.0K | 869.9K | -4% | -$2.40M |
| DT | 2023-07-21 | 2023-07-19 | TXG | Saxonov Serge | CEO, Dir | M - OptEx | $0.00 | -20.8K | 32.5K | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-07-19 | M | A | 20,845 | $5.04 | 909,850 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-07-19 | S | D | 40,000 | $60.03 | 869,850 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $60.00 to $60.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Derivative | Stock Option (right to buy) | 2023-07-19 | M | D | 20,845 | $0.00 | 32,478 | D | $5.04 · — to 2028-11-02 | 20,845 Class A Common Stock | (F7) All of the shares subject to the option are fully vested and exercisable as of the date hereof. |